Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study sheds light on guinea pig neoplasia
It had been previously considered that tumour prevalence in guinea pigs was low.

Tumour prevalence increases with age.

Tumour prevalence is higher in guinea pigs than previously thought, according to new research.

The study led by the University of Veterinary Medicine Vienna used autopsy reports collected from three pathology institutes in Germany, Austria and the USA. Of the 2,474 guinea pigs autopsied, the team found tumours in 508 cases (21 per cent of guinea pigs), and multiple tumours in 95 cases. 

Leukaemia or lymphomas were the most common tumours,
particularly in younger animals, with lymph nodes, liver and spleen being the most frequently affected organs. Non-lymphoid tumours were most commonly found in the female genital tract (mostly the uterus), lungs, skin, thyroid gland and gastrointestinal tract.

It had been previously considered that tumour prevalence in guinea pigs was low – based on research on laboratory animals which are typically younger. However, this new study found a tumour in one in five guinea pigs, which is higher than for pet rabbits studied at the same institution. 

Moreover, the team found that tumour prevalence increased with age – from one per cent in guinea pigs under 0.5 years old to 54 per cent for animals over five years old. 

The authors write: ‘Our postmortem study demonstrates a high prevalence of disseminated lymphoma or leukaemia in pet guinea pigs at the time of death or euthanasia. Additional studies are needed to further characterize these tumors.’

The research, Neoplasia in pet guinea pigs: a retrospective analysis of 2,474 autopsy examinations, is published in the Journal of Veterinary Diagnostic Investigation

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.